Co-Authors
This is a "connection" page, showing publications co-authored by PING FAN and PHILIPP MAXIMOV.
Connection Strength
1.289
-
Estrogen Receptor Complex to Trigger or Delay Estrogen-Induced Apoptosis in Long-Term Estrogen Deprived Breast Cancer. Front Endocrinol (Lausanne). 2022; 13:869562.
Score: 0.206
-
The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer Cells. Mol Pharmacol. 2020 07; 98(1):24-37.
Score: 0.181
-
Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer. Mol Pharmacol. 2018 08; 94(2):812-822.
Score: 0.158
-
A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers. Endocr Relat Cancer. 2018 02; 25(2):R83-R113.
Score: 0.153
-
Progesterone and Synthetic Progestin Controversies. JAMA Oncol. 2015 Oct; 1(7):986-7.
Score: 0.132
-
Integration of Downstream Signals of Insulin-like Growth Factor-1 Receptor by Endoplasmic Reticulum Stress for Estrogen-Induced Growth or Apoptosis in Breast Cancer Cells. Mol Cancer Res. 2015 Oct; 13(10):1367-76.
Score: 0.130
-
The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy. Mol Cell Endocrinol. 2015 Dec 15; 418 Pt 3:245-63.
Score: 0.129
-
Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast Cancer. Mol Cancer Ther. 2021 01; 20(1):11-25.
Score: 0.047
-
Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERa-positive breast cancer. Explor Target Antitumor Ther. 2020; 1:355-371.
Score: 0.047
-
Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer. Mol Pharmacol. 2020 10; 98(4):364-381.
Score: 0.046
-
Sex steroid induced apoptosis as a rational strategy to treat anti-hormone resistant breast and prostate cancer. Discov Med. 2016 05; 21(117):411-27.
Score: 0.034
-
Models and Mechanisms of Acquired Antihormone Resistance in Breast Cancer: Significant Clinical Progress Despite Limitations. Horm Mol Biol Clin Investig. 2012 Feb; 9(2):143-163.
Score: 0.026